Msicspharma
1 known investors
MSICS Pharma develops naturally-sourced psilocybin products for pharmaceutical use, operating a GMP production facility that produces its flagship product MSX-06. The product is undergoing clinical trials with hospitals to treat mental health conditions including depression, OCD, anxiety, PTSD, and eating disorders.
Investors · 1
Frequently asked questions
- What does Msicspharma do?
- MSICS Pharma develops naturally-sourced psilocybin products for pharmaceutical use, operating a GMP production facility that produces its flagship product MSX-06. The product is undergoing clinical trials with hospitals to treat mental health conditions including depression, OCD, anxiety, PTSD, and eating disorders.
- Who are Msicspharma's investors?
- Msicspharma's investors include Fusion VC.